Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00755_DB01259_nanopub.RAGGcu3JyZdA6SEsjpyvsRZy21_EluPgm6dy4q8Im4MDE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00755_DB01259 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00755_DB01259 label "DDI between Tretinoin and Lapatinib - The moderate CYP2C8 inhibitor, Lapatinib, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Lapatinib is initiated, discontinued to dose changed. [drugbank_resource:DB00755_DB01259]" assertion.
- drugbank_resource:DB00755_DB01259 identifier "drugbank_resource:DB00755_DB01259" assertion.
- drugbank_resource:DB00755_DB01259 title "DDI between Tretinoin and Lapatinib - The moderate CYP2C8 inhibitor, Lapatinib, may decrease the metabolism and clearance of oral Tretinoin. Monitor for changes in Tretinoin effectiveness and adverse/toxic effects if Lapatinib is initiated, discontinued to dose changed." assertion.
- drugbank:DB01259 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01259 assertion.
- drugbank:DB00755 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00755_DB01259 assertion.